These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3566488)

  • 21. Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs: Part I.
    Abdel-Rahman RM; Morsy JM; Hanafy F; Amene HA
    Pharmazie; 1999 May; 54(5):347-51. PubMed ID: 10368828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synthesis and pharmacologic profile of new diaryl as-triazines].
    Pitet G; Rochas MA; Stenger A; Delhon A
    Boll Chim Farm; 1985 Jun; 124(6):271-8. PubMed ID: 3877513
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis and pharmacological activity of 1-(arylsulfonyl)-3,5-dialkyl-s-triazine-2,4,6-(1H,3H,5H)-triones.
    Holcomb GN; Klemm LA; Silhavy TJ; Counsell RE
    J Pharm Sci; 1973 Aug; 62(8):1379-81. PubMed ID: 4725196
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis of some tetrahydronaphthyl-1,2,4-triazines of possible schistosomicidal activity.
    Nabih I; Zayed AA; Metri J; Kamel M; Motawia MS
    Pharmazie; 1984 Dec; 39(12):862-3. PubMed ID: 6531399
    [No Abstract]   [Full Text] [Related]  

  • 25. [Trichomonacidal drugs. 6. 2,4-Dichloro derivatives of piperidino- and piperazinyl-1,3,5-triazine].
    Kreutzberger A; Kochanowski R
    Arzneimittelforschung; 1987 Sep; 37(9):999-1002. PubMed ID: 3501724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Derivatives of diamino-1,3,5-triazine. I. Synthesis of some derivatives of 2-amino-4-(5-ethyl-4-methyl-2-pyrazoline)-1,3,5-triazine with potential hypoglycemic effect].
    Brzozowski Z; Kozakiewicz I
    Acta Pol Pharm; 1980; 37(6):601-5. PubMed ID: 7293804
    [No Abstract]   [Full Text] [Related]  

  • 27. Design, Synthesis, and Docking Study of Pyrimidine-Triazine Hybrids for GABA Estimation in Animal Epilepsy Models.
    Sahu M; Siddiqui N; Naim MJ; Alam O; Yar MS; Sharma V; Wakode S
    Arch Pharm (Weinheim); 2017 Sep; 350(9):. PubMed ID: 28758238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some substituted imidazo[1,2-b] [1,2,4]triazines and 8H-pyrimido[1,2-b] [1,2,4]triazin-8-ones as potential antineoplastic agents.
    Labouta IM; Soliman FS; Kassem MG
    Pharmazie; 1986 Nov; 41(11):812-3. PubMed ID: 3562515
    [No Abstract]   [Full Text] [Related]  

  • 29. Design, synthesis, and molecular docking study of benzothiazolotriazine derivatives for anticonvulsant potential.
    Firdaus JU; Habib A; Siddiqui N; Alam O; Naim MJ; Partap S; Sahu M
    Arch Pharm (Weinheim); 2018 Dec; 351(12):e1800154. PubMed ID: 30479053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of some new heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anti-cancer drugs, Part II.
    Abdel-Rahman RM; Morsy JM; el-Edfawy S; Amine HA
    Pharmazie; 1999 Sep; 54(9):667-71. PubMed ID: 10522270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antimycotic agents. 22. Chlor-(1-piperazinyl)-1,3,5-triazines].
    Kreutzberger A; Kochanowski R
    Arch Pharm (Weinheim); 1988 Dec; 321(12):836-40. PubMed ID: 3245760
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on as-triazine derivatives. XVIII. Synthesis of 5,6-diaryl-1,2,4-triazine derivatives as blood platelet aggregation inhibitors].
    Konno S; Kokubo T; Amano M; Yoshida N; Sagi M; Yamanaka H
    Yakugaku Zasshi; 1992 Oct; 112(10):729-41. PubMed ID: 1469603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irreversible enzyme inhibitors. CX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. IV.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jan; 11(1):34-7. PubMed ID: 5237172
    [No Abstract]   [Full Text] [Related]  

  • 34. [Central depressive substances. 7. Nuclear substituted (diallylamino)-1,3,5-triazines].
    Kreutzberger A; Schläfer I
    Arch Pharm (Weinheim); 1988 Nov; 321(11):827-30. PubMed ID: 3219052
    [No Abstract]   [Full Text] [Related]  

  • 35. [Analgesic drugs. 11. Diacyl derivatives of butyroguanamine].
    Kreutzberger A; Loch M
    Arch Pharm (Weinheim); 1986 Mar; 319(3):275-7. PubMed ID: 3718180
    [No Abstract]   [Full Text] [Related]  

  • 36. [Synthesis and hypoglycemic properties of the new derivatives of 4-(2-aminoethyl)benzenesulfonamide and 1,2-dihydro-1,3,5-triazine].
    Gajewski F
    Acta Pol Pharm; 1982; 39(5-6):485-8. PubMed ID: 7171018
    [No Abstract]   [Full Text] [Related]  

  • 37. Irreversible enzyme inhibitors. CIX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. 3.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jan; 11(1):26-33. PubMed ID: 5237171
    [No Abstract]   [Full Text] [Related]  

  • 38. 2-amino-2-thiazoline. VI. The formation of a thiazolo-S-triazine from 2-amino-2-thiazoline.
    Klayman DL; Milne GW
    Tetrahedron; 1969 Jan; 25(1):191-8. PubMed ID: 5346201
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis of the pyrimido [5,4-e]-as-triazine antibiotics fervenulin and 2-methylfevenulone.
    Taylor EC; Sowinski F
    J Org Chem; 1975 Aug; 40(16):2321-29. PubMed ID: 1177058
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs, part III.
    el-Gendy Z; Morsy JM; Allimony HA; Ali WR; Abdel-Rahman RM
    Pharmazie; 2001 May; 56(5):376-83. PubMed ID: 11400552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.